NCT02215941View on ClinicalTrials.gov

Study to Characterize the Pharmacokinetics and Safety of TV-45070 Ointment in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

February 28, 2015

Conditions
Pharmacokinetics
Interventions
DRUG

TV-45070

TV-45070 8% ointment

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

Teva Investigational Site 12961, Lenexa

All Listed Sponsors
lead

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY

NCT02215941 - Study to Characterize the Pharmacokinetics and Safety of TV-45070 Ointment in Healthy Volunteers | Biotech Hunter | Biotech Hunter